PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer

Introduction: Endocrine therapy has played an important role in the management of ER positive breast cancer over recent decades. Despite this, not all patients respond equally to endocrine intervention, which can lead to resistance, associated disease relapse and progression. Previous reports sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Rees, Michael, Smith, Chris, Barrett-Lee, Peter, Hiscox, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771710/
https://www.ncbi.nlm.nih.gov/pubmed/33473257
http://dx.doi.org/10.18632/oncotarget.27846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771710/
https://www.ncbi.nlm.nih.gov/pubmed/33473257
http://dx.doi.org/10.18632/oncotarget.27846

Ejemplares similares